Kkm Regulatory Compliance Sop: Npra Reporting & Standards

STANDARD OPERATING PROCEDURE (SOP): NPRA REGULATORY COMPLIANCE

Document Control Number: [________________]
Effective Date: [________________]
Revision Number: [________________]

---

1. PURPOSE

The purpose of this Standard Operating Procedure (SOP) is to establish a formal framework for ensuring continuous regulatory compliance with the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia (KKM). This document mandates adherence to the Control of Drugs and Cosmetics Regulations 1984 and all associated guidelines.

2. SCOPE

This procedure applies to all personnel, departments, and third-party contractors involved in the import, manufacture, distribution, storage, and post-market surveillance of pharmaceutical, cosmetic, and traditional health products managed by [_________________ Company Name].

3. REGULATORY OBLIGATIONS

[_________________ Company Name] shall ensure that:

• All products are registered with the NPRA prior to market entry.
• The Product Registration Holder (PRH) maintains valid registration status.
• Mandatory Post-Market Surveillance (PMS) and Adverse Drug Reaction (ADR) reporting are conducted within the statutory timeframes.
• Advertising and promotional materials comply with the Medicines (Advertisement and Sale) Act 1956.

4. COMPLIANCE PROCEDURES

4.1 Product Registration & Maintenance

• Registration Coordinator: [_________________ Name/Designation]
• NPRA QUEST System Access ID: [_________________]
• Compliance Timeline: All renewal applications must be submitted no later than [_______] days prior to expiration.

4.2 Adverse Event Reporting (Pharmacovigilance)

Any adverse event identified must be documented and reported to the NPRA via the QUEST system within [_______] hours of initial discovery.

• Primary Contact for PV: [_________________ Name]
• Reporting Email: [_________________]

4.3 Change Management

Prior to any change in product formulation, manufacturing site, or secondary packaging, a formal application for a "Variation" must be submitted to the NPRA.

• Verification Officer: [_________________ Name]
• Required Lead Time for Review: [_______] weeks.

5. AUDIT AND INSPECTION

Periodic internal audits shall be conducted to verify compliance with Good Manufacturing Practice (GMP), Good Distribution Practice (GDP), and Good Storage Practice (GSP).

• Next Scheduled Internal Audit: [_________________ Date]
• Audit Reference Number: [_________________]

6. NON-COMPLIANCE PROTOCOL

In the event of a regulatory breach, the [_________________ Designation/Title] must be notified immediately. A Corrective and Preventive Action (CAPA) report must be initiated within [_______] business days.

---

7. AUTHORIZATION AND SIGNATURES

Prepared By:
Name: [________________________________]
Designation: [________________________________]
Date: [________________________________]
Signature: ________________________________

Reviewed By (Quality Assurance/Regulatory Affairs):
Name: [________________________________]
Designation: [________________________________]
Date: [________________________________]
Signature: ________________________________

Approved By (Management/Director):
Name: [________________________________]
Designation: [________________________________]
Date: [________________________________]
Signature: ________________________________

---

CONFIDENTIALITY NOTICE: This document contains proprietary information regarding regulatory compliance protocols. Unauthorized disclosure or distribution is strictly prohibited under the internal policy of [_________________ Company Name] and applicable Malaysian laws.